DK0906303T3 - Ringannellerede dihydropyraner, fremgangsmåde til deres fremstilling samt anvendelse deraf - Google Patents

Ringannellerede dihydropyraner, fremgangsmåde til deres fremstilling samt anvendelse deraf

Info

Publication number
DK0906303T3
DK0906303T3 DK97928221T DK97928221T DK0906303T3 DK 0906303 T3 DK0906303 T3 DK 0906303T3 DK 97928221 T DK97928221 T DK 97928221T DK 97928221 T DK97928221 T DK 97928221T DK 0906303 T3 DK0906303 T3 DK 0906303T3
Authority
DK
Denmark
Prior art keywords
preparation
dihydropyrans
processes
ring annealed
annealed
Prior art date
Application number
DK97928221T
Other languages
English (en)
Inventor
Stephan Henke
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0906303T3 publication Critical patent/DK0906303T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)
DK97928221T 1996-06-18 1997-06-18 Ringannellerede dihydropyraner, fremgangsmåde til deres fremstilling samt anvendelse deraf DK0906303T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19624154A DE19624154A1 (de) 1996-06-18 1996-06-18 Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
PCT/EP1997/003146 WO1997048691A1 (de) 1996-06-18 1997-06-18 Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung

Publications (1)

Publication Number Publication Date
DK0906303T3 true DK0906303T3 (da) 2003-07-28

Family

ID=7797180

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97928221T DK0906303T3 (da) 1996-06-18 1997-06-18 Ringannellerede dihydropyraner, fremgangsmåde til deres fremstilling samt anvendelse deraf

Country Status (11)

Country Link
US (1) US6399653B1 (da)
EP (1) EP0906303B1 (da)
JP (1) JP4181219B2 (da)
AT (1) ATE236895T1 (da)
AU (1) AU3259997A (da)
CA (1) CA2258539C (da)
DE (2) DE19624154A1 (da)
DK (1) DK0906303T3 (da)
ES (1) ES2193380T3 (da)
PT (1) PT906303E (da)
WO (1) WO1997048691A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6137560A (en) 1995-10-23 2000-10-24 Hitachi, Ltd. Active matrix type liquid crystal display apparatus with light source color compensation
EP1137418A2 (en) * 1998-12-02 2001-10-04 Pfizer Products Inc. METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
JP2007526917A (ja) * 2004-02-20 2007-09-20 アベンティス・ファーマスーティカルズ・インコーポレイテツド Ｈｍ７４のオキシデカヒドロナフタレンモジュレーター
US7750015B2 (en) * 2005-05-17 2010-07-06 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
US7737155B2 (en) * 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
CA2608405A1 (en) * 2005-05-17 2006-11-23 Schering Corporation Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia
KR20080091814A (ko) * 2006-01-20 2008-10-14 쉐링 코포레이션 지질혈증장애의 치료를 위한 니코틴산 수용체 효능제로서의헤테로사이클
US11932655B1 (en) 2023-10-17 2024-03-19 King Faisal University 12-bromo-2,16-dioxapentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione as an antimicrobial compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3775435A (en) * 1971-08-26 1973-11-27 American Home Prod 5,6,7,8-tetrahydro-2,5(and 4,5)-dioxo-1-benzopyrans
GB9318431D0 (en) 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
WO1997048691A1 (de) 1997-12-24
DE59709792D1 (de) 2003-05-15
JP4181219B2 (ja) 2008-11-12
CA2258539C (en) 2009-06-02
JP2000512305A (ja) 2000-09-19
CA2258539A1 (en) 1997-12-24
ES2193380T3 (es) 2003-11-01
EP0906303B1 (de) 2003-04-09
EP0906303A1 (de) 1999-04-07
PT906303E (pt) 2003-08-29
AU3259997A (en) 1998-01-07
ATE236895T1 (de) 2003-04-15
DE19624154A1 (de) 1998-01-08
US6399653B1 (en) 2002-06-04

Similar Documents

Publication Publication Date Title
DK1019368T3 (da) Acylsulfamoylbenzoesyreamider, nytteplantebeskyttelsesmidler indeholdende disse samt fremgangsmåder til deres fremstilling
ES2056214T3 (es) Compuestos de benzopirido-piperidina, -piperidilideno y -piperazina, composiciones, metodos de preparacion y metodos de uso.
NO971684L (no) Nye benzoxazoler
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
BRPI0612141A2 (pt) derivados de quinuclidina substituìdos com biciclo-heterociclos fundidos
ATE231496T1 (de) Saccharinderivate als proteolytische enzyminhibitoren
NO983487L (no) Derivater av camptothecin for anvendelse ved behandling av kreft
ATE233250T1 (de) Saccharinderivate als proteolytische enzyminhibitoren
DK0923554T3 (da) N-Benzylpiperidin- og tetrahydropyridinderivater
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
IS4404A (is) Afleiður steróla til stýringar rýrisskiptingu
ATE294152T1 (de) Substituierte tetrahydro-naphtaline und analoge verbindungen
PT956286E (pt) Sintese de terfenadina e derivados
NO971625L (no) Nye peptider med immunomodulatoriske effekter
NO894410L (no) Fremgangsmaate for fremstilling av 3,5-dimetyl-4-metoksypyridinderivater samt nye mellomprodukter for dette formaal.
DK0906303T3 (da) Ringannellerede dihydropyraner, fremgangsmåde til deres fremstilling samt anvendelse deraf
DK0649846T3 (da) Galanthaminderivater, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
MXPA03007380A (es) Derivados de imidazol 2-tio sustituidos y el uso de los mismos en la industria farmaceutica.
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
ES2152563T3 (es) Procedimiento para preparar derivados de dihidroxipirimidina.
ID26210A (id) Proses pemurnian turunan sefalosporin
BR0107823A (pt) Processo para a obtenção de ácido fórmico anidro ou substancialmente anidro, uso de uma carboxamida, e, aparelho para realizar um processo
DK1001961T3 (da) Substituerede derivater af tetrahydrofuran og fremgangsmåde til deres fremstilling
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.